FDA-Authorized Tinnitus Treatment Targets Root Causes of Ringing in the Ears
Innovative Bimodal Neuromodulation Device Combines Sound and Tongue Stimulation to Reduce Tinnitus Symptoms
TEMPE, AZ, May 16, 2026 /24-7PressRelease/ — Dr. Rohe at the Tinnitus & Hearing Center of Arizona is pleased to announce the availability of Lenire®, an FDA-authorized tinnitus treatment device designed to reduce the severity of tinnitus through a clinically proven, non-invasive approach. Lenire represents a significant advancement in tinnitus care by addressing the neurological activity associated with tinnitus rather than simply masking symptoms.
Bimodal Neuromodulation: A New Approach to Tinnitus Relief
Lenire works by delivering bimodal neuromodulation, a patented treatment that combines auditory stimulation through headphones with gentle electrical stimulation to the tongue via a device called the Tonguetip®. This synchronized stimulation helps retrain the brain’s neural pathways involved in tinnitus perception.
Key features of the Lenire system include:
– Dual Stimulation Therapy: Combines precisely timed sound and tongue stimulation to promote beneficial neuroplastic changes in the brain
– Customized Treatment Programs: Individually programmed by hearing care professionals based on each patient’s tinnitus profile
– At-Home Use: Portable and designed for daily use, typically 30–60 minutes per session
– Clinically Supported Outcomes: Backed by large-scale clinical studies showing significant reduction in tinnitus symptom severity for many patients
Clinically Guided, Personalized Care
At Tinnitus & Hearing Center of Arizona, Lenire treatment is delivered as part of a comprehensive tinnitus management program. Patients undergo a detailed assessment to determine candidacy and receive ongoing support and adjustments throughout their treatment journey.
Unlike traditional approaches that rely on sound masking or coping strategies alone, Lenire is designed to produce lasting improvements by targeting the underlying neural mechanisms of tinnitus.
A Non-Invasive Alternative for Chronic Tinnitus
Lenire offers a drug-free, non-surgical option for individuals experiencing persistent tinnitus. Many patients report improvements in tinnitus loudness, intrusiveness, and overall quality of life after consistent use.
This makes it an ideal solution for individuals who have not found sufficient relief from hearing aids, sound therapy, or other conventional treatments.
Availability
Lenire is now available at Tinnitus & Hearing Center of Arizona. Due to growing demand and the need for individualized treatment planning, patients are encouraged to schedule a consultation in advance.
For more information or to book a tinnitus assessment, visit tinnitusaz.com.
About Tinnitus & Hearing Center of Arizona
Tinnitus & Hearing Center of Arizona is a leading provider of advanced tinnitus care and hearing solutions. With a focus on evidence-based treatment and personalized care, Audiologists Allen and Amy Rohe specialize in helping patients find meaningful, long-term relief from tinnitus and hearing challenges.
Tinnitus & Hearing Center of Arizona is a Tempe-based specialty clinic dedicated to helping patients find relief from tinnitus and hearing loss. Founded to fill a gap in care for people struggling with ringing in the ears, the clinic offers evidence-based treatment options including The Rohe Method®, tinnitus retraining therapy, hearing aid solutions, and customized hearing care. With over 30 years of experience and care for more than 35,000 patients since 2002, the practice combines advanced technology, clinical expertise, and personalized support to help patients improve their hearing and quality of life.
—
For the original version of this press release, please visit 24-7PressRelease.com here
Legal Disclaimer: This article was provided by an independent third-party content provider. Kyrion Media makes no warranties or representations in connection with it. All information is provided “as is” without warranty of any kind. This content may not have been reviewed by our editorial staff and is published automatically. The views expressed in this article are those of the author and do not necessarily reflect the views of Kyrion Media. All trademarks are the property of their respective owners. If you are affiliated with this article and would like it removed, please contact retract@kyrionmedia.com.
